[1] |
WU Jialu, GE Xia, CHEN Wenming, YANG Guangzhong.
Current status and progress of CAR-T cell therapy in multiple myeloma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 525-531.
|
[2] |
WANG Huijuan, CHEN Wenming, GENG Chuanying, YANG Guangzhong .
Clinical characteristics of patients with relapsed/refractory multiple myeloma after CAR-T cell therapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 549-553.
|
[3] |
LIANG Yuanzheng, WANG Henan, WANG Liang.
Effects of PPP2R5C on proliferation, apoptosis, and drug sensitivity of multiple myeloma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 405-411.
|
[4] |
ZHOU Da, WANG Mingyue, LI Zhe, HE Qing, CEN Hong.
Single-center clinical experience of daratumumab combined with bendamustine in the treatment of multiple myeloma patients with secondary extramedullary disease
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 412-416.
|
[5] |
CHEN Xiaolei, ZHANG Yong, ZHANG Yue, LI Jie, ZHOU Hebing .
Retrospective analysis of efficacy and prognosis of newly diagnosed multiple myeloma patients with 1q21 amplification
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 541-547.
|
[6] |
QIU Lin, TONG Yang, JIN Yongmei.
Evidence for sexual health management of breast cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(4): 434-439.
|
[7] |
ZHONG Wuning, KANG Wei, WANG Zhonghai, ZHAO Xin, SU Danke.
Correlation between come beam breast computed tomography features and HER2 expression in non⁃mass enhancement breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(4): 429-434.
|
[8] |
WANG Jia, ZHAI Zhimin, GE Jian, WANG Xingbing, DONG Yi.
Effects of extramedullary diseases and regulatory T cells on the treatment efficacy of chimeric antigen receptor T cells in multiple myeloma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(4): 400-406.
|
[9] |
LYU Yi, ZHANG Xinyu, NIE Huifang, LI Xun.
Analysis of cancer mortality trend of urban residents in Shenyang,2013—2017
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 629-634.
|
[10] |
YANG Guangzhong, GENG Chuanying, WU Yin, LIU Aijun, LENG Yun, LI Yanchen, GAO Wen, CHEN Wenming.
Clinical efficacy of domestic bortezomib (Xintai) in the treatment of multiple myeloma and its safety
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(4): 385-388.
|
[11] |
CHEN Jigui, ZHAO Chang, CHEN Chao, XU Jun, LI Zhiqiang, ZHANG Mei, ZHOU Qiong.
Total resection of retroperitoneal liposarcoma for recurrent retroperitoneal liposarcoma: 4 cases report and literature review
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(6): 686-690.
|
[12] |
GAO Peng, XIAO Zhongping, FU Kun, FENG Tao, YANG Dan, HAN Mei.
Expression of lncRNA MEG3 and lncRNA GAS5 in serum of multiple myeloma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(4): 313-318.
|
[13] |
Wang Fang,Li Yanxiu,Tang Yuping,Xiong Lixiang,Pang Chun,Xie Qi,Qi Rongjuan.
Effects of multidisciplinary collaboration-based clinical pathway management on quality of life of patients with laryngectomy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(1): 71-74.
|
[14] |
XIANG Bangde, ZHANG Zhiming, YUAN Weiping, MA Liang, QIU Jingfeng, LI Lequn.
Associating liver partition and portal vien ligation for staged hepatectomy:a case report and literature review
[J]. Chinese Journal of Oncology Prevention and Treatment, 2015, 7(4): 264-268.
|
[15] |
LI Xiang,MO Xin-shao,CHEN Si-xia,YANG Yi-lan.
Effects of intraoperative and postoperative hypothermia on recovery in patients with large hepatocellular carcinoma undergoing hepatectomy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2014, 6(1): 74-77.
|